2 June 2020 - Innovative medical products offer significant and potentially transformative impacts on health, but they create concerns about rising ...
31 January 2020 - Reflecting experience with previous framework, benchmarking with other HTA groups, and input from more than 100 organisations ...
9 September 2019 - Value assessment frameworks have emerged as tools to assist health care decision makers in the United States ...
21 August 2019 - Reflecting experience with current framework, benchmarking with other HTA groups, and public input, proposals include new emphasis ...
15 August 2019 - ICER invites all patient organizations and the general public to attend a webinar to learn more ...
20 June 2019 - The second plenary session focused on the need to move beyond conventional cost-effectiveness analysis of healthcare interventions ...
2 May 2019 - Accepting Open Input Through 10 June 2019. ...
22 February 2018 - Value assessment is an integral component of decision making in health and is the focus of a ...
26 December 2018 - Patient preferences should be a central consideration in healthcare decision making. ...
13 November 2017 - Broader societal considerations and expanded cost-effectiveness ranges will be included for treatments targeting fewer than 10,000 patients. ...
6 September 2017 - In 1996, the U.S. Panel on Cost-Effectiveness in Health and Medicine recommended that analysts conducting cost-effectiveness ...
7 September 2017 - America’s healthcare debate has stalled in Congress, but constructive dialogue and innovation are thriving in specialised ...
23 July 2017 - Health technology assessment is a tool that helps to objectively evaluate evidence, which levels the playing field ...
25 July 2017 - ICER’s fundamental approach to value assessment remains constant with proposed changes for special circumstances. ...
22 June 2017 - Responds to public comment and sets key parameters for evidence review methods and process for stakeholder engagement. ...